{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:58:09Z","timestamp":1790517489750,"version":"4.1.0"},"reference-count":59,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T00:00:00Z","timestamp":1451433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The hand, foot and mouth disease is caused by a group of Enteroviruses such as Enterovirus 71 (EV-A71) and Coxsackievirus CV-A5, CV-A8, and CV-A16. Mild symptoms of EV-A71 infection in children range from high fever, vomiting, rashes and ulcers in mouth but can produce more severe symptoms such as brainstem and cerebellar encephalitis, leading up to cardiopulmonary failure and death. The lack of vaccines and antiviral drugs against EV-A71 highlights the urgency of developing preventive and treatment agents against EV-A71 to prevent further fatalities. Research groups have developed experimental inactivated vaccines, recombinant Viral Protein 1 (VP1) vaccine and virus-like particles (VLPs). The inactivated EV-A71 vaccine is considered the safest viral vaccine, as there will be no reversion to the infectious wild type strain. The recombinant VP1 vaccine is a cost-effective immunogen, while VLPs contain an arrangement of epitopes that can elicit neutralizing antibodies against the virus. As each type of vaccine has its advantages and disadvantages, increased studies are required in the development of such vaccines, whereby high efficacy, long-lasting immunity, minimal risk to those vaccinated, safe and easy production, low cost, dispensing the need for refrigeration and convenient delivery are the major goals in their design.<\/jats:p>","DOI":"10.3390\/v8010001","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T10:25:05Z","timestamp":1451471105000},"page":"1","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Development of Novel Vaccines against Enterovirus-71"],"prefix":"10.3390","volume":"8","author":[{"given":"Pinn","family":"Yee","sequence":"first","affiliation":[{"name":"Virology Research Group, Vice Chancellor\u2019s Office, Sunway University, Bandar Sunway, Kuala Lumpur, Selangor 47500, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chit","family":"Poh","sequence":"additional","affiliation":[{"name":"Virology Research Group, Vice Chancellor\u2019s Office, Sunway University, Bandar Sunway, Kuala Lumpur, Selangor 47500, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.coviro.2011.07.009","article-title":"Viruses\u2014From pathogens to vaccine carriers","volume":"1","author":"Small","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008\u201312: An epidemiological study","volume":"14","author":"Xing","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/rmv.538","article-title":"Genetic evolution of enterovirus 71: Epidemiological and pathological implications","volume":"17","author":"Bible","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"ref_4","unstructured":"Knipe, D.M., Howley, P.M., Cohen, J.I., Griffin, D.E., Lamb, R.A., Martin, M.A., Racaniello, V.R., and Roizman, B. (2003). Fields Virology, Lippincott Williams & Wilkins. [6th ed.]."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/rmv.1827","article-title":"Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014","volume":"25","author":"Liu","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Evans, A.S., and Kaslow, R.A. (1997). Viral Infections of Humans, Plenum.","DOI":"10.1007\/978-1-4899-0036-4"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1474-4422(10)70209-X","article-title":"Clinical features, diagnosis, and management of enterovirus 71","volume":"9","author":"Ooi","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM199909233411301","article-title":"An epidemic of enterovirus 71 infection in Taiwan","volume":"341","author":"Ho","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/1471-2334-13-489","article-title":"Enterovirus genotypes causing hand foot and mouth disease in Shanghai, China: A molecular epidemiological analysis","volume":"13","author":"Xu","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0168-1702(95)00087-9","article-title":"Complete nucleotide sequence of Enterovirus 71 is distinct from poliovirus","volume":"39","author":"Brown","year":"1995","journal-title":"Virus Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1128\/JVI.01019-09","article-title":"Evolutionary genetics of human enterovirus 71: Origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene","volume":"84","author":"Tee","year":"2010","journal-title":"J. Virol."},{"key":"ref_12","unstructured":"Picornaviridae. Available online: http:\/\/viralzone.expasy.org\/all_by_species\/33.html."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/mr.60.3.499-511.1996","article-title":"RNA-protein interactions in regulation of picornavirus RNA translation","volume":"60","author":"Belsham","year":"1996","journal-title":"Microbiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0092-8674(86)90790-7","article-title":"A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein","volume":"45","author":"Toyoda","year":"1986","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1074\/jbc.M707907200","article-title":"Picornavirus genome replication: Identification of the surface of the poliovirus (PV) 3C dimer that interacts with PV 3Dpol during VPg uridylylation and construction of a structural model for the PV 3C2\u20133Dpol complex","volume":"283","author":"Shen","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1099\/0022-1317-83-6-1367","article-title":"Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death","volume":"83","author":"Kuo","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/viro.2001.1310","article-title":"The 3C protease activity of Enterovirus 71 induces human neural cell apoptosis","volume":"293","author":"Li","year":"2002","journal-title":"Virology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","article-title":"An apparently new enterovirus isolated from patients with disease of the central nervous system","volume":"129","author":"Schmidt","year":"1974","journal-title":"J. Infect. Dis."},{"key":"ref_19","unstructured":"The Dermatologic Image Database, Department of Dermatology, University of Iowa College of Medicine, USA. Available online: http:\/\/tray.dermatology.uiowa.edu\/ImageBase."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/338819","article-title":"The 1998 Enterovirus 71 outbreak in Taiwan: Pathogenesis and management","volume":"34","author":"Lin","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sabanathan, S., Tan, L.V., Thwaites, L., Wills, B., Qui, P.T., and van Doorn, H.R. (2014). Enterovirus 71 related severe hand, foot and mouth disease outbreaks in South-East Asia: Current situation and ongoing challenges. J. Epidemiol. Commun. Health, 1\u20133.","DOI":"10.1136\/jech-2014-203836"},{"key":"ref_22","unstructured":"WHO Emerging Disease Surveillance and Response: Hand, Foot and Mouth Disease (HFMD). Available online: http:\/\/www.wpro.who.int\/emerging_diseases\/HFMD\/en\/."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-422X-9-8","article-title":"Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications","volume":"9","author":"Xu","year":"2012","journal-title":"Virol. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4161\/hv.24949","article-title":"Progress on the research and development of inactivated EV71 whole-virus vaccines","volume":"9","author":"Liang","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0264-410X(01)00385-1","article-title":"Protection against lethal Enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus","volume":"20","author":"Wu","year":"2001","journal-title":"Vaccine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1099\/vir.0.80784-0","article-title":"Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys","volume":"86","author":"Arita","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1128\/JVI.02856-06","article-title":"An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys","volume":"81","author":"Arita","year":"2007","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.vaccine.2013.05.019","article-title":"Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"Foo","year":"2007","journal-title":"Microbes Infect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1016\/j.vaccine.2012.09.030","article-title":"Cross-reactive neutralizing antibody epitopes against enterovirus 71 identified by an in silico approach","volume":"30","author":"Kirk","year":"2012","journal-title":"Vaccine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-0556-5-6","article-title":"DNA vaccine constructs against Enterovirus 71 elicit immune response in mice","volume":"5","author":"Tung","year":"2007","journal-title":"Genet. Vaccines Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an Enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant Enterovirus 71 vaccine in children in china: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/cid\/ciu852","article-title":"Review of Enterovirus 71 vaccines","volume":"60","author":"Chong","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1016\/j.vaccine.2005.12.047","article-title":"Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from Enterovirus 71","volume":"24","author":"Chen","year":"2006","journal-title":"Vaccine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1743-422X-8-106","article-title":"Antibody dependent enhancement infection of Enterovirus 71 in vitro and in vivo","volume":"8","author":"Han","year":"2011","journal-title":"Virol. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/viro.2000.0627","article-title":"Antibody-dependent induction of type I interferons by poliovirus in human mononuclear blood cells requires the type II Fc\u03b3 receptor (CD32)","volume":"278","author":"Palmer","year":"2000","journal-title":"Virology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1099\/0022-1317-83-2-351","article-title":"Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain","volume":"83","author":"Girn","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1038\/cti.2014.24","article-title":"EV71 vaccine, an invaluable gift for children","volume":"3","author":"Liang","year":"2014","journal-title":"Clin. Trans. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12916-015-0448-7","article-title":"Immunity and clinical efficacy of an inactivated Enterovirus 71 vaccine in healthy Chinese children: A report of further observations","volume":"13","author":"Liu","year":"2015","journal-title":"BMC Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Mao, Q., Dong, C., Li, X., Gao, Q., Guo, Z., Yao, X., Wang, Y., Gao, F., Li, F., and Xu, M. (2012). Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046043"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4161\/hv.21739","article-title":"Production of EV71 vaccine candidates","volume":"8","author":"Chong","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1016\/j.vaccine.2011.04.070","article-title":"Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection","volume":"29","author":"Bek","year":"2011","journal-title":"Vaccine"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhang, H., An, D., Liu, W., Mao, Q., Jin, J., Xu, L., Sun, S., Jiang, L., Li, X., and Shao, J. (2014). Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100545"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1038\/emi.2014.29","article-title":"EV71 vaccines: A milestone in the history of global vaccine development","volume":"3","author":"Lu","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1574-6976.2000.tb00532.x","article-title":"Heterologous protein expression in the methylotrophic yeast Pichia pastoris","volume":"24","author":"Cereghino","year":"2000","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Mellado","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.vaccine.2015.03.034","article-title":"High-yield production of recombinant virus-like particles of Enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice","volume":"33","author":"Zhang","year":"2015","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"831282","DOI":"10.1155\/2012\/831282","article-title":"Immunological evaluation and comparison of different EV71 vaccine candidates","volume":"2012","author":"Chou","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/bit.25625","article-title":"Enhanced enterovirus 71 virus-like particle yield from a new baculovirus design","volume":"112","author":"Lin","year":"2015","journal-title":"Biotechnol. Bioeng."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Tsou, Y.L., Lin, Y.W., Shao, H.Y., Yu, S.L., Wu, S.R., Lin, H.Y., Liu, C.C., Huang, C., Chong, P., and Chow, Y.H. (2015). Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003692"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1038\/srep07878","article-title":"Novel recombinant chimeric virus-like particle is immunogenic and protective against both Enterovirus 71 and Coxsackievirus A16 in mice","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"12973","DOI":"10.1038\/srep12973","article-title":"A broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of Enterovirus 71","volume":"5","author":"Xu","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1074\/jbc.M114.624536","article-title":"Crystal structures of EV71 recombinant virus particles provide insights into vaccine design","volume":"290","author":"Lyu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1128\/JVI.00422-15","article-title":"Crystal structures of yeast-produced enterovirus 71 and enterovirus 71\/coxsackievirus A16 chimeric virus-like particles provide the structural basis for novel vaccine design against hand-foot-and-mouth disease","volume":"89","author":"Lyu","year":"2015","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1073\/pnas.1300233110","article-title":"Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.1218713","article-title":"Crystal structure of human Enterovirus 71","volume":"336","author":"Plevka","year":"2012","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nsmb.2255","article-title":"A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71","volume":"19","author":"Wang","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nri2801","article-title":"Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design","volume":"10","author":"Cardozo","year":"2010","journal-title":"Nat. Rev. Immunol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/8\/1\/1\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:54:45Z","timestamp":1760216085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/8\/1\/1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,30]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1]]}},"alternative-id":["v8010001"],"URL":"https:\/\/doi.org\/10.3390\/v8010001","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,30]]}}}